KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma

Julia Ingruber1, Dragana Savic2,3, Teresa Bernadette Steinbichler1

  • 1Department of Otorhinolaryngology and Head and Neck Surgery, Medical University of Innsbruck, University Hospital of Tyrol, A-6020 Innsbruck, Austria.

Cells
|April 3, 2021
PubMed

Insights

In head and neck squamous cell carcinoma (HNSCC), epithelial to mesenchymal transition (EMT) involves decreased Krüppel-like factor 4 (KLF4) and increased Slug. Transforming growth factor-beta-1 and p53 mutations influence these EMT regulators.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Epithelial to mesenchymal transition (EMT) is a critical process in cancer progression, particularly in head and neck squamous cell carcinoma (HNSCC).
  • EMT involves the downregulation of epithelial markers and upregulation of mesenchymal markers, contributing to tumor invasion and metastasis.
  • Krüppel-like factor 4 (KLF4) is recognized as an anti-EMT factor, while EMT-transcription factors (EMT-TFs) like Slug promote EMT.

Purpose of the Study:

  • To investigate the roles of EMT-TFs and KLF4 in regulating EMT in HNSCC.
  • To explore the relationship between KLF4, EMT-TFs (specifically Slug), and clinical parameters in HNSCC.
  • To elucidate potential molecular pathways involving transforming growth factor-beta-1 (TGF-β1) and p53 in HNSCC-associated EMT.

Main Methods:

  • Analysis of EMT-TFs, KLF4, and vimentin mRNA and protein expression in HNSCC tissues and cell lines.
  • Comparison of gene expression between HNSCC samples and normal mucosa.
  • Correlation analysis between KLF4, Slug, human papilloma virus (HPV) status, and p53 gene sequence irregularities.

Main Results:

  • Slug gene expression was significantly elevated, while KLF4 gene expression was significantly reduced in HNSCC compared to normal mucosa.
  • A significant inverse correlation was observed between KLF4 and Slug gene expression in most HNSCC samples.
  • Slug expression was higher in HPV-negative HNSCC and tumors with irregular p53 sequences; TGF-β1 promoted KLF4 downregulation and Slug upregulation.

Conclusions:

  • KLF4 downregulation and Slug upregulation are key features of EMT in HNSCC.
  • TGF-β1 signaling and p53 mutations represent potential pathways driving EMT in HNSCC by modulating KLF4 and Slug.
  • These findings highlight KLF4 and Slug as potential therapeutic targets for HNSCC treatment.